Skip to content
healthcare.dev

Protonix Delayed-Release

NDC 0008-0844, PANTOPRAZOLE SODIUM, granule, delayed release, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

Product NDC
0008-0844
Status
Listed
Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Dosage form
GRANULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0008-0844 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANTOPRAZOLE SODIUM40 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
0008-0844-020000808440230 PACKET in 1 CARTON (0008-0844-02) / 1 GRANULE, DELAYED RELEASE in 1 PACKET (0008-0844-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/08098cb2-c048-4640-f387-6beec4a38936
  • NADAC price for package 00008084402

    GET /v1/drugs/nadac/00008084402

Use it

Look up 0008-0844 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0008-0844 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0008-0844. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.